EXCLUSIVE: Adial Pharmaceuticals Signs Exclusive AD04 Agreement With Molteni Farmaceutici For Europe; Deal Anticipates Nearly $60M Potential Royalties, Milestones
Adial Pharmaceuticals, Inc. +3.80%
Adial Pharmaceuticals, Inc. ADIL | 1.64 | +3.80% |
EXCLUSIVE: Adial Pharmaceuticals Signs Exclusive AD04 Agreement With Molteni Farmaceutici For Europe; Deal Anticipates Nearly $60M Potential Royalties, Milestones
